Spectral Medical 2024 Investor Presentation

Spectral Medical is a Phase 3 biotech company developing Toraymyxin (PMX), a therapeutic hemoperfusion device for treating septic shock, alongside its FDA-cleared Endotoxin Activity Assay diagnostic. The company combines targeted diagnostics with endotoxin-removal therapy to improve outcomes for septic shock patients and reduce mortality rates.